Evidence map›Paper›PMID 38602558›Full record

SynthesisCurrent HIV/AIDS reports2024

The Impact of Cannabis Use on Cognition in People with HIV: Evidence of Function-Dependent Effects and Mechanisms from Clinical and Preclinical Studies.

Samantha M Ayoub, Breanna M Holloway, Alannah H Miranda, Benjamin Z Roberts, Jared W Young, Arpi Minassian, Ronald J Ellis

Abstract readSystematic Review
In one paragraph

Synthesis in Current HIV/AIDS reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Low-Dose Cannabidiol Treatment does not Alter Cognitive Performance in the HIV-1 Transgenic Rat Model of NeuroHIV.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Risk factors for cognitive decline in persons with HIV.Current opinion in infectious diseases · 2025
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Samantha M AyoubDepartment of Psychiatry, University of California San Diego, 9500 Gilman Drive MC 0804, La Jolla, CA, 92093-0804, USA. sayoub@health.ucsd.edu.
Breanna M HollowayDepartment of Psychiatry, University of California San Diego, 9500 Gilman Drive MC 0804, La Jolla, CA, 92093-0804, USA.
Alannah H MirandaDepartment of Psychiatry, University of California San Diego, 9500 Gilman Drive MC 0804, La Jolla, CA, 92093-0804, USA.
Benjamin Z RobertsDepartment of Psychiatry, University of California San Diego, 9500 Gilman Drive MC 0804, La Jolla, CA, 92093-0804, USA.
Jared W YoungDepartment of Psychiatry, University of California San Diego, 9500 Gilman Drive MC 0804, La Jolla, CA, 92093-0804, USA.
Arpi MinassianDepartment of Psychiatry, University of California San Diego, 9500 Gilman Drive MC 0804, La Jolla, CA, 92093-0804, USA.
Ronald J EllisDepartment of Neuroscience, University of California San Diego, La Jolla, CA, USA.

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Maile Ann Young Karris · 1994 to 2026
$78.4M
Fellowship on Biological Psychiatry and NeuroscienceT32MH018399 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Pei-an (Betty) Shih · 1986 to 2026
$7.3M
Interdisciplinary Research Fellowship in NeuroAIDSR25MH081482 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MARIANA CHERNER · 2007 to 2026
$5.2M
Translational Studies of Cannabis Administration, Cognition, and the Endocannabinoid System in HIVR01DA051295 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MINASSIAN, ARPI, YOUNG, JARED WILLIAM · 2021 to 2025
$4.3M
Cannabis use and the endocannabinoid system in bipolar disorderR01DA043535 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PERRY, WILLIAM, YOUNG, JARED WILLIAM · 2018 to 2022
$3.3M
NIAID NIH HHS P30 AI036214NIDA NIH HHS R01 DA043535NIDA NIH HHS R01DA043535NIDA NIH HHS R01 DA051295NIDA NIH HHS R01DA051295NIH HHS 2R25MH081482-16NIH HHS T32MH018399NIMH NIH HHS R25 MH081482NIMH NIH HHS T32 MH018399
6 · The paper itself

Abstract

purpose of reviewCannabis may have beneficial anti-inflammatory effects in people with HIV (PWH); however, given this population's high burden of persisting neurocognitive impairment (NCI), clinicians are concerned they may be particularly vulnerable to the deleterious effects of cannabis on cognition. Here, we present a systematic scoping review of clinical and preclinical studies evaluating the effects of cannabinoid exposure on cognition in HIV. RECENT

findingsResults revealed little evidence to support a harmful impact of cannabis use on cognition in HIV, with few eligible preclinical data existing. Furthermore, the beneficial/harmful effects of cannabis use observed on cognition were function-dependent and confounded by several factors (e.g., age, frequency of use). Results are discussed alongside potential mechanisms of cannabis effects on cognition in HIV (e.g., anti-inflammatory), and considerations are outlined for screening PWH that may benefit from cannabis interventions. We further highlight the value of accelerating research discoveries in this area by utilizing translatable cross-species tasks to facilitate comparisons across human and animal work.

Indexed as

CognitionHIV InfectionsAnimalsCannabinoidsCannabisCognitive DysfunctionHumansMarijuana UseCannabinoidsCannabinoidsCognitionHIV-associated neurocognitive disordersNeuroHIV

Identifiers

PMID38602558
PMCPMC11129923

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.